Rose Pharmaincis A Clinical Stage Biopharmaceutical Company Developing A Differentiatedshort Acting Glp 1 Designed To Fill The Critical Market Gap In Weight Loss Maintenanceimproved Tolerabilityand Ibs Pain Reduction With A Multi Billion Dollar Market Opportunityour Phase 2B Asset Offers A High Value Commercial Potential In The Rapidly Expanding Glp 1 Space We Are Actively Seeking Corporate Partnerships For Development And Commercialization Of Rose10 In Ibs Pain And Weight Management
No conferences found for this company.
| Company Name | Rose Pharma As |
| Country |
Denmark
|
| Address | N/A |
| Telephone | N/A |
| N/A |
Enter your address and we will specify the offer for your area.